Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
Authors
Keywords
-
Journal
RHEUMATOLOGY INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-06-18
DOI
10.1007/s00296-021-04917-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19, rheumatic diseases and immune dysregulation—a perspective
- (2021) Shahna Tariq et al. CLINICAL RHEUMATOLOGY
- Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic
- (2021) Sakir Ahmed et al. RHEUMATOLOGY INTERNATIONAL
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
- (2021) Raches Ella et al. LANCET INFECTIOUS DISEASES
- SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis
- (2021) Tsvetelina Velikova et al. RHEUMATOLOGY INTERNATIONAL
- Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis
- (2021) Qingxiu Wang et al. RHEUMATOLOGY INTERNATIONAL
- Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study
- (2021) George E. Fragoulis et al. RHEUMATOLOGY INTERNATIONAL
- Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases
- (2021) Caoilfhionn M Connolly et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- A practical approach for vaccinations including COVID-19 in autoimmune/autoinflammatory rheumatic diseases: a non-systematic review
- (2021) Mehmet Soy et al. CLINICAL RHEUMATOLOGY
- Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?
- (2021) Søren Dinesen Østergaard et al. LANCET
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients with Rheumatic and Musculoskeletal Diseases – Version 1
- (2021) Jeffrey R Curtis et al. Arthritis & Rheumatology
- Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India
- (2020) Padmanabha Shenoy et al. CLINICAL RHEUMATOLOGY
- Determinants of COVID-19 disease severity in patients with underlying rheumatic disease
- (2020) C. Sieiro Santos et al. CLINICAL RHEUMATOLOGY
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Management of vaccination in rheumatic disease
- (2019) Peter K.K. Wong et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2019) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started